Vitamin K2 Function
Vitamin K2 (menaquinone) activates vitamin K-dependent proteins throughout the body, playing critical roles in blood coagulation, bone metabolism, and cardiovascular health by ensuring proper calcium deposition in bones while preventing vascular calcification.
Primary Biological Functions
Vitamin K2 serves as an essential cofactor for the enzyme γ-glutamyl carboxylase (GGCX), which carboxylates glutamic acid residues on vitamin K-dependent proteins (VKDPs) 1, 2. This carboxylation process is necessary for these proteins to become biologically active.
Key Functional Areas:
Blood Coagulation
- Activates hepatic coagulation factors essential for normal blood clotting
- Deficiency leads to prolonged prothrombin time and bleeding risk 1
Bone Health
- Activates osteocalcin, the major non-collagenous protein in bone matrix 3
- Contributes to structural integrity of bone and proper calcium incorporation
- Low intake is linked to increased bone loss and fracture risk in both sexes 3
- Deficiency contributes to poor bone development and osteoporosis 1
Cardiovascular Protection
- Activates matrix Gla-carboxyglutamic acid protein, which prevents calcium deposition in arterial walls 1
- Addresses the "calcium paradox" - ensuring calcium goes to bones rather than blood vessels 4
- Deficiency is associated with increased cardiovascular disease 1
Additional Emerging Roles
- Anti-inflammatory effects through suppression of NF-κB signal transduction 1
- Potential roles in inhibiting cell ferroptosis 5
- Possible epigenetic effects through modulation of DNA methylation and histone modifications 6
Important Clinical Distinctions
Vitamin K2 differs from Vitamin K1 (phylloquinone) in several critical ways:
- Different chemical structure and pharmacokinetics affecting bioavailability and metabolism 2
- Greater bioavailability than other vitamin K forms 7
- More effective at activating extra-hepatic vitamin K-dependent proteins (like osteocalcin and matrix Gla protein) compared to K1 2
- K2 accounts for up to 25% of total vitamin K intake 2
Clinical Caveats
Current guideline limitations: The 2022 ESPEN guidelines note that adequate intake recommendations are established for vitamin K1 only, due to lack of sufficient data for vitamin K2 1. This represents a significant knowledge gap given K2's distinct properties and functions.
Deficiency risk factors include:
- Fat malabsorption conditions (celiac disease, cystic fibrosis, short bowel syndrome)
- Malnutrition
- Prolonged broad-spectrum antibiotic use (disrupts gut bacterial production)
- Warfarin/anticoagulant therapy 1
Safety profile: Vitamin K2 is not associated with toxicity and is considered safe when ingested as a dietary supplement 1, 7. This contrasts with synthetic vitamin K3, which is highly toxic and no longer available.
Anticoagulant interactions: Patients on vitamin K antagonists require monitoring, as K2 intake affects anticoagulation control. However, stable control is achievable with dose titration when vitamin K intake is known and consistent 1.